PharmaCyte Biotech annual free cash flow
2013
2014
2015
2016
PharmaCyte Biotech Free Cash Flow (FCF) History (PMCB)
PharmaCyte Biotech reported −$4.3M in free cash flow for fiscal 2016, an increase of $213,763 from the previous fiscal year.
View full PharmaCyte Biotech company overviewPharmaCyte Biotech free cash flow by year
| Fiscal year | Period ended | Free cash flow | Change | Growth | FCF margin |
|---|---|---|---|---|---|
| 2016 | 2016-04-30 | −$4.3M | $213,763 | — | — |
| 2015 | 2015-04-30 | −$4.6M | $494,539 | — | — |
| 2014 | 2014-04-30 | −$5.1M | −$4.0M | — | — |
| 2013 | 2013-04-30 | −$1.0M | — | — | −8529.41% |
PharmaCyte Biotech quarterly free cash flow
Q3.13
Q3.14
Q3.15
| Fiscal quarter | Period ended | Free cash flow | Change | YoY growth | FCF margin |
|---|---|---|---|---|---|
| Q3 2015 | 2015-01-31 | −$1.3M | −$1.1M | — | — |
| Q3 2014 | 2014-01-31 | −$249,699 | −$172,104 | — | — |
| Q3 2013 | 2013-01-31 | −$77,595 | — | — | — |
PharmaCyte Biotech free cash flow growth trends
PharmaCyte Biotech's latest reported quarter, Q3 2015, generated −$1.3M in free cash flow, a decrease of $1.1M year over year.
About the metric
What free cash flow means
Free cash flow is the cash a company generates from operations after capital expenditures. Positive FCF can fund dividends, buybacks, debt repayment, or reinvestment; negative FCF means capital spending exceeded operating cash flow for that period.
Calculation and source
How free cash flow is calculated
TickerStat calculates free cash flow as reported operating cash flow minus capital expenditures. FCF margin equals free cash flow divided by revenue. Fiscal periods can differ from calendar years, so the tables include exact period-end dates.
Review PharmaCyte Biotech source filings ↗